S&P 500
7,520.20
+0.01%
Dow Jones
52,424.00
-0.19%
Nasdaq 100
29,413.00
+0.52%
Russell 2000
2,949.86
-0.05%
FTSE 100
10,447.00
-0.61%
Nikkei 225
67,760.10
+1.04%

Health and Healthcare

Discovery Labs Shareholders Get Smacked on Secondary Offering (DSCO)

Photo of Paul Ausick
By Paul Ausick Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Invalid Image
Respiratory drug maker Discovery Laboratories Inc. (NASDAQ: DSCO) priced a secondary offering of slightly more than 16 million shares this morning, and the stock is getting pummeled as a result. Discovery priced the shares at $2.80, a discount of 20% to yesterday’s closing price of $3.50.

The company expects to realize net proceeds of $42.1 million from the share sale. The underwriters have a 30-day over-allotment option of about 2.41 million shares. Lazard Capital Markets LLC is the sole book-running manager for the offering, Stifel Nicolaus Weisel is co-lead manager, and ROTH Capital Partners, LLC is co-manager of the offering.

The shares are being offered from a shelf registration filed yesterday. The company did not indicate how the net proceeds would be used.

Shares of Discovery Labs are down -18% at $2.87 in a 52-week range of $1.44-$5.39.

Contact [email protected] for any questions or corrections.

*$149 for two years (or $1.43 per week) is an introductory promotion for new members only. 62% discount based on the current list price of Stock Advisor of $199/year. Membership will renew at the then-current list price at the end of the membership term.

Stock Advisor returns are 930% as compared to the S&P 500 returns of 185% as of April 7, 2026.

Follow 24/7 Wall St. on Google
Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Continue Reading

Coal-Miner Peabody’s Secondary Offering Costs the Company $40 Million
Paul Ausick |

Coal-Miner Peabody’s Secondary Offering Costs the Company $40 Million

Peabody Energy priced an underwritten secondary stock offering on Thursday. None of the proceeds from the sale will benefit Peabody,…

Moderna Commits to $500 Million Capital Raise, With More Possible
Jon C. Ogg |

Moderna Commits to $500 Million Capital Raise, With More Possible

Moderna Inc. (NASDAQ: MRNA) had been the biggest biotech initial public offering ever. The company was quite unlucky in the…

Idera Pharmaceuticals Sinks on Secondary Offering
Chris Lange |

Idera Pharmaceuticals Sinks on Secondary Offering

Shares of Idera Pharmaceuticals sank on Thursday after the company announced that it intends to have a secondary offering.

Chris Lange |

La Jolla Gears Up for Secondary Offering

La Jolla Pharmaceuticals has announced the pricing of an underwritten offering of 2.55 million shares of its common stock.

Douglas A. McIntyre |

Companies Raising Additional Capital (CPST, DDSS, PUDA, SNMX, SSRI, YRCW)

We are still seeing many companies trying to capitalize off of raising capital or where holders are registering shares.  Companies…

Stealth Bio Gears Up for IPO
Chris Lange |

Stealth Bio Gears Up for IPO

Clinical-stage biotechnology company Stealth Biotherapeutics has filed with the SEC regarding its initial public offering.

Chris Lange |

Calithera Files for IPO to Fund Cancer Tumor Therapy Projects

Calithera Biosciences files with the U.S. Securities and Exchange Commission to conduct an initial public offering.

3 New Biotech IPOs on Calendar for Next Week
Paul Ausick |

3 New Biotech IPOs on Calendar for Next Week

Blank-check company KLR Energy Acquisition Corp. (NASDAQ: KLREU) completed its initial public offering (IPO) last Friday, the first successful IPO…

IPO Calendar Lists 4 Biotechs for Coming Week
Paul Ausick |

IPO Calendar Lists 4 Biotechs for Coming Week

Three initial public offerings (IPOs) went off as scheduled last week and four are on the calendar for the coming…

Top Gaining Stocks

FactSet Research Systems
FDS • Vol: 929,614
Gartner
IT • Vol: 1,375,344
Intuit
INTU • Vol: 6,564,709
Valero Energy
VLO • Vol: 2,870,552
Paycom Software
PAYC • Vol: 620,867

Top Losing Stocks

Coterra Energy
CTRA • Vol: 73,319,495
Oracle
ORCL • Vol: 56,688,573
Intel
INTC • Vol: 100,754,655
Lam Research
LRCX • Vol: 9,770,514
ON Semiconductor
ON • Vol: 9,568,853